Compare HTGC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HTGC | LGND |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 2004 | 1997 |
| Metric | HTGC | LGND |
|---|---|---|
| Price | $16.94 | $302.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $18.86 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 1.3M | 164.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 12.13% | N/A |
| EPS Growth | 14.91 | ★ 2886.36 |
| EPS | 0.90 | ★ 1.63 |
| Revenue | N/A | ★ $141,102,000.00 |
| Revenue This Year | $11.18 | $1.25 |
| Revenue Next Year | $5.24 | $19.41 |
| P/E Ratio | ★ $18.67 | $183.46 |
| Revenue Growth | N/A | ★ 29.48 |
| 52 Week Low | $13.70 | $166.10 |
| 52 Week High | $19.17 | $326.63 |
| Indicator | HTGC | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 65.55 |
| Support Level | $16.37 | $286.99 |
| Resistance Level | $17.15 | $317.49 |
| Average True Range (ATR) | 0.30 | 8.66 |
| MACD | -0.12 | 2.57 |
| Stochastic Oscillator | 19.77 | 99.79 |
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.